Review: taking Doxepin hydrochloride and Zantac 150 together


Summary

Drug interactions are reported among people who take Doxepin hydrochloride and Zantac 150 together. This review analyzes the effectiveness and drug interactions between Doxepin hydrochloride and Zantac 150. It is created by eHealthMe based on reports of 420 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Doxepin hydrochloride and Zantac 150 >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Doxepin Hydrochloride

Doxepin hydrochloride has active ingredients of doxepin hydrochloride. It is often used in depression. (latest outcomes from Doxepin hydrochloride 794 users)

Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 4,145 users)

On Aug, 30, 2016

420 people who take Doxepin Hydrochloride, Zantac 150 are studied.


Number of reports submitted per year:

Doxepin hydrochloride and Zantac 150 drug interactions.

Drug effectiveness over time:

Doxepin Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 4 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Zantac 150:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Doxepin Hydrochloride:
  • female: 20.0% - (1 of 5 people)
  • male: 0.0% - (0 of 4 people)
Zantac 150:
  • female: 40.0% - (2 of 5 people)
  • male: 100.0% - (4 of 4 people)

Drug effectiveness by age:

Doxepin Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 3 people)
Zantac 150:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 60.0% - (3 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (3 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • constipation
  • death
  • peritonitis
  • convulsion
  • plasmacytoma
  • abdominal pain upper
  • gastrointestinal perforation
  • intestinal perforation
  • pain
  • abdominal adhesions
1 - 6 months:
  • pulmonary embolism
  • burning sensation
  • chest pain
  • drug ineffective
  • dyspnoea
  • night sweats
  • pain
  • pancreatitis
  • sleep
  • systemic mastocytosis
6 - 12 months:
  • hemorrhoids
  • itching in the groin
  • skin burning sensation
  • skin rash
  • tinea of the scalp
  • chills
  • confusional state
  • drug toxicity
  • encephalopathy
  • hypotension
1 - 2 years:
  • arthritis
  • bipolar ii disorder
  • bone disorder
  • chronic obstructive pulmonary disease
  • depression
  • fall
  • foot fracture
  • gastric disorder
  • gastric infection
  • injury
2 - 5 years:
  • abdominal discomfort
  • abdominal pain upper
  • diarrhoea
  • drug hypersensitivity
  • dry mouth
  • dysphagia
  • facial pain
  • gastric ulcer
  • gastritis
  • headache
5 - 10 years:
  • anxiety
  • depression
  • hallucination, auditory
  • hallucination, visual
  • insomnia
  • paranoia
  • psychotic disorder
  • suicide attempt
  • hypotension
  • metabolic encephalopathy
10+ years:
  • chronic depression
  • abscess
  • androgen deficiency
  • ankylosing spondylitis
  • attention deficit/hyperactivity disorder
  • bone density decreased
  • bone disorder
  • chronic obstructive pulmonary disease
  • convulsion
  • death
not specified:
  • nausea
  • pyrexia
  • pain
  • depression
  • anxiety
  • fall
  • headache
  • dizziness
  • arthralgia
  • chest pain

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • headache
  • depression
  • anxiety
  • dyspnoea
  • arthralgia
  • pyrexia
  • dizziness
  • fall
male:
  • pyrexia
  • somnolence
  • hypotension
  • chills
  • depression
  • confusional state
  • chest pain
  • fall
  • metabolic encephalopathy
  • anxiety

Most common drug interactions by age *:

2-9:
  • dermatitis exfoliative
  • disease recurrence
10-19:
  • abdominal discomfort
  • abdominal pain
  • anxiety
  • asthma
  • cholecystitis infective
  • depression
  • dyspepsia
  • dyspnoea
  • erythema
  • feeling abnormal
20-29:
  • completed suicide
  • depression
  • anxiety
  • drug ineffective
  • insomnia
  • vomiting
  • abdominal pain
  • decreased appetite
  • diarrhoea
  • drug abuser
30-39:
  • anxiety
  • depression
  • dizziness
  • sedation
  • sinusitis
  • arthralgia
  • bronchitis
  • dysuria
  • migraine
  • night sweats
40-49:
  • nausea
  • type 2 diabetes mellitus
  • depression
  • cognitive disorder
  • injury
  • memory impairment
  • convulsion
  • conversion disorder
  • diabetes mellitus
  • musculoskeletal discomfort
50-59:
  • nausea
  • headache
  • pain
  • myalgia
  • pyrexia
  • chest pain
  • dizziness
  • fatigue
  • anxiety
  • insomnia
60+:
  • pruritus
  • pyrexia
  • pain in extremity
  • hypotension
  • fall
  • oedema peripheral
  • constipation
  • pain
  • chills
  • confusional state

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Doxepin hydrochloride and Zantac 150?

Can you answer these questions?

More questions for: Doxepin hydrochloride, Zantac 150

You may be interested in these reviews

More reviews for: Doxepin hydrochloride, Zantac 150

On eHealthMe, Doxepin hydrochloride (doxepin hydrochloride) is often used to treat depression. Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.